Gastrointestinal Cancers

GASTROINTESTINAL CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Bevacizumab + Atezolizumab: Survival and Quality-of-Life Benefits in Advanced Liver Cancer Spur Regulatory Approval

Phase 3 clinical trial of combination shows survival and quality-of-life benefits vs the standard of care, sorafenib, leading to the regimen’s expedited regulatory approval.
Has the Time for At-Home Cancer Care Finally Come?

A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19.
A Single Chromosomal Gain in Cancer Can Either Inhibit or Drive Disease

Although some tumors lack aneuploidy or have few extra chromosomal copies, others have a slew of mutations.
Genomics Industry Tries New Strategies to Engage Community Oncologists

Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing.
A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials

The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated.

GASTROINTESTINAL CANCER NEWS

Nurse checks blood glucose of patient.

Antidiabetic Medication Adherence, Survival for Patients With Diabetes and Colorectal Cancer

June 23, 2020

FDA_drug approval

Opdivo Approved for Advanced Esophageal Squamous Cell Carcinoma

June 12, 2020

liver affected by cirrhosis and hepatitis

Study to Evaluate Synergy of 3-Drug Combo in HCC, Liver-Dominant Cancers

June 12, 2020

An overview of the potential immune-related adverse events that can arise from treatment with checkp

Comparing Stereotactic Body Radiation Therapy With Transarterial Chemoembolization in Early-Stage HCC

June 12, 2020

Lenvatinib, Pembrolizumab Combination Promising in Unresectable HCC

June 12, 2020

Next post in Gastrointestinal Cancers

A nurse records the vitals of a patient.

Evidence Supports Efficacy, Safety of Sorafenib in Older Hispanic Patients With Advanced HCC